who discovered glp-1 The Discovery of Glucagon-Like Peptide 1 (GLP-1) Metabolic Messengers: glucagon-like peptide 1

Its stability in human gastric juice and potential oral bioactivity make it a rare peptide with possible systemic benefits even when taken non-injectably

You dont have to dig through the privacy policy or terms of service to find it

It has shown potential in: Neutralizing toxic products of lipid peroxidation

The endogenous biosynthesis which mainly takes place in the liver, kidney, and to some extent in the brain, meets only 25% of the carnitine required by the human body, while the remaining 75% is obtained from the diet under regular diet regimen, i.e., consuming either meat, fish, dairy product, and vegetables (Longo et al., 2006